Cost-Effectiveness of Tenofovir Instead of Zidovudine for Use in First-Line Antiretroviral Therapy in Settings without Virological Monitoring

BACKGROUND: The most recent World Health Organization (WHO) antiretroviral treatment guidelines recommend the inclusion of zidovudine (ZDV) or tenofovir (TDF) in first-line therapy. We conducted a cost-effectiveness analysis with emphasis on emerging patterns of drug resistance upon treatment failur...

Full description

Saved in:
Bibliographic Details
Main Authors: von Wyl, Viktor, Cambiano, Valentina, Jordan, Michael R., Bertagnolio, Silvia, Miners, Alec, Pillay, Deenan, Lundgren, Jens, Phillips, Andrew N.
Format: Artigo
Language:Inglês
Published: Public Library of Science 2012
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3414499/
https://ncbi.nlm.nih.gov/pubmed/22905175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0042834
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items